» Articles » PMID: 30249743

Comparative Analysis of the Capacity of the Species To Elicit Vaginal Immunopathology

Overview
Journal Infect Immun
Date 2018 Sep 26
PMID 30249743
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The human fungal pathogen is the major etiological agent of vulvovaginal candidiasis (VVC). Despite this fact, other non- (NAC) species have frequently been reported, as well. Despite their presence in the vaginal environment, little is known about their capacities to elicit immune responses classically associated with -mediated immunopathology, including neutrophil recruitment and proinflammatory cytokine signaling. Therefore, using a combination of and approaches, we undertook a comparative analysis to determine whether a representative panel of NAC species could colonize, induce immunopathological markers, or cause damage at the vaginal mucosa. Using a murine model of VVC, was found to induce robust immunopathology (neutrophils and interleukin 1β [IL-1β]) and elicit mucosal damage. However, all the NAC species tested (including , , , , , and ) induced significantly less damage and neutrophil recruitment than , despite achieving similar early colonization levels. These results largely correlated with a notable lack of ability by the NAC species (including and ) to form hyphae both and Furthermore, both and induced significantly less expression of the gene encoding candidalysin, a key fungal virulence determinant driving VVC immunopathology. In order to determine the relative capacities of these species to elicit inflammasome-dependent IL-1β release, both wild-type and NLRP3 THP-1 cells were challenged While most species tested elicited only modest amounts of IL-1β, challenge with led to significantly elevated levels that were largely NLRP3 dependent. Collectively, our findings demonstrate that although NAC species are increasingly reported as causative agents of VVC, appears to be exceedingly vaginopathogenic, exhibiting robust immunopathology, hypha formation, and candidalysin expression. Thus, this study provides mechanistic insight into why is overwhelmingly the major pathogen reported during VVC.

Citing Articles

Host-microbe interaction paradigms in acute and recurrent vulvovaginal candidiasis.

MacAlpine J, Lionakis M Cell Host Microbe. 2024; 32(10):1654-1667.

PMID: 39389030 PMC: 11469575. DOI: 10.1016/j.chom.2024.08.018.


Inflammatory cytokine signalling in vulvovaginal candidiasis: a hot mess driving immunopathology.

Cheng K, Montano D, Zelante T, Dietschmann A, Gresnigt M Oxf Open Immunol. 2024; 5(1):iqae010.

PMID: 39234208 PMC: 11374039. DOI: 10.1093/oxfimm/iqae010.


Innate immune response to Candida auris.

Holt A, Nett J Curr Opin Microbiol. 2024; 80:102510.

PMID: 38964276 PMC: 11323126. DOI: 10.1016/j.mib.2024.102510.


Vertebrate and invertebrate animal infection models of Candida auris pathogenicity.

Martinez M, Garsin D, Lorenz M Curr Opin Microbiol. 2024; 80:102506.

PMID: 38925077 PMC: 11432150. DOI: 10.1016/j.mib.2024.102506.


Vulvovaginal candidiasis culture results from a major national commercial laboratory, United States, 2019-2023.

Benedict K, Smith D, Lyman M, Gold J Am J Obstet Gynecol. 2024; 231(3):e101-e104.

PMID: 38710271 PMC: 11344687. DOI: 10.1016/j.ajog.2024.04.048.


References
1.
Shi X, Yang Y, Zhang Y, Li W, Wang J, Huang W . Molecular identification and antifungal susceptibility of 186 Candida isolates from vulvovaginal candidiasis in southern China. J Med Microbiol. 2015; 64(Pt 4):390-393. DOI: 10.1099/jmm.0.000024. View

2.
De Vos M, Cuenca-Estrella M, Boekhout T, Theelen B, Matthijs N, Bauters T . Vulvovaginal candidiasis in a Flemish patient population. Clin Microbiol Infect. 2005; 11(12):1005-11. DOI: 10.1111/j.1469-0691.2005.01281.x. View

3.
Staab J, Bradway S, Fidel P, Sundstrom P . Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999; 283(5407):1535-8. DOI: 10.1126/science.283.5407.1535. View

4.
Kumar D, Banerjee T, Pratap C, Tilak R . Itraconazole-resistant Candida auris with phospholipase, proteinase and hemolysin activity from a case of vulvovaginitis. J Infect Dev Ctries. 2015; 9(4):435-7. DOI: 10.3855/jidc.4582. View

5.
Kalaiarasan K, Singh R, Chaturvedula L . Fungal Profile of Vulvovaginal Candidiasis in a Tertiary Care Hospital. J Clin Diagn Res. 2017; 11(3):DC06-DC09. PMC: 5427306. DOI: 10.7860/JCDR/2017/23578.9475. View